Business Wire

Hyperice Unveils Next Generation of Contrast Therapy Innovation, Hyperice X 2 Knee and Hyperice X 2 Shoulder

19.8.2025 16:00:00 EEST | Business Wire | Press release

Share

Hyperice, a global high-performance wellness brand, today announced the global launch of Hyperice X 2, the next generation of its best-selling Hyperice X contrast therapy line. Born from the acquisition of RecoverX in 2021 and refined through athlete testing, Hyperice X 2 is the most advanced portable contrast therapy device on the market. The Hyperice X 2 Knee and Hyperice X 2 Shoulder feature major upgrades from their predecessor devices, including deeper cold, stronger heat, and a built-in compression system to aid athletes and active users with more effective warm-up and recovery strategies.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250819036830/en/

Driven by athlete feedback, the new Hyperice X 2 unlocks a new era of contrast recovery tech with powerful multi-level compression. With advanced technology tested and proven by athletes, Hyperice X 2 Knee and Hyperice X 2 Shoulder bring elite-level warm-up and recovery contrast therapy solutions in a new, user-friendly device designed for everyday use.

Hyperice X 2 marks the most substantial evolution in technology from its first-generation product. The breakthrough innovation was built and refined through a rigorous feedback loop with elite athletes. Every detail, from contrast and compression ranges to fit and portability, has been accounted for, ensuring the product meets the demands of elite athletes on the sideline alongside everyday individuals.

“Recovery and wellness are fundamental to living well, from professional athletes to people of all ages,” said Jim Huether, CEO of Hyperice. “Our mission is to provide the most advanced and effective solutions to help people move, feel, and perform better every day. With Hyperice X 2 Shoulder and Hyperice X 2 Knee, we’re not just advancing recovery, we’re redefining it. This next generation maintains the mobility and power of its predecessor while seamlessly fusing contrast therapy and compression into a sleek, more practical design.”

With advanced technology tested and proven by athletes, Hyperice X 2 Knee and Hyperice X 2 Shoulder bring elite-level warm-up and recovery contrast therapy solutions in a new, user-friendly device designed for everyday use. Whether training, rehabbing from injury or surgery, or staying active on the go, users can prime their bodies, recover faster, and perform at their best.

Key Features:

  • Addition of compression: Five levels of compression (up to 160mmHg) push temperatures deeper into the tissue, allowing users to tailor the compression to their needs and achieve a more customized fit.
  • Targeted contrast therapy: Expanded temperature ranges now span from 40°F (4°C) to 121°F (49°C), with five levels of cooling and five levels of heating, to ease inflammation and boost circulation as needed. Up from the original Hyperice X range at 45°F (7°C) to 113°F (45°C).
  • Smart control and all-in-one mobility: A new all-in-one OLED display allows seamless switching between hot, cold, and contrast therapy, as well as select compression levels. Hyperice X 2 is cord-free for use on the move, with an option to plug in to the wall for extended rehab sessions.
  • Manual and Bluetooth compatibility: New to Hyperice X 2, users can use the device with or without Bluetooth connectivity to the Hyperice app, allowing pros to leverage the technology on the sidelines easier than ever before.
  • Extended battery life: Up to 1.5 hours of continuous portable use (1 hour on max cold, 1 hour on max contrast, and 1.5 hours on max heat) - 34% more capacity compared to the original Hyperice X line.
  • Lightweight and portable: Just 2.5 lbs and TSA-friendly, Hyperice X 2 Knee and Hyperice X 2 Shoulder prioritize portability and ease of use. Each device is designed to fit both the right and left sides, to allow for increased versatility and on-the-go therapy.

From Generation 1 to Game-Changer

Building on the success of the original Hyperice X Knee and Hyperice X Shoulder models, Hyperice X 2 uses thermoelectric systems to deliver instant heat and cold temperatures on demand, without the need for ice or liquid. Hyperice X 2 introduces a clinically inspired multi-level compression system that drives temperatures deeper into tissue, ultra-convenient on-device smart controls, and cord-free portability. Now, this athlete-endorsed technology comes in a lightweight, portable device designed to help anyone, anytime, anywhere.

“I’ve put everything into this off-season to come back stronger, and recovery is where that work pays off with the Hyperice X 2 Shoulder playing a major role in my routine,” said Jayden Daniels, Washington Commanders quarterback and Hyperice athlete. “I can push my limits on the field because the built-in compression elevates my warm-up, and the contrast therapy helps me bounce back quickly for peak performance.”

Benefits of contrast therapy include:

  • Reduces swelling and pain: Contrast moves fluid, while compression limits buildup to ease inflammation and discomfort.
  • Relaxes muscles and boosts circulation: Heat loosens tight muscles, cold calms spasms, and both, paired with compression, improve blood flow.
  • Improves range of motion: Reduces stiffness, mobilizes joints, and softens tissue for smoother, safer movement.
  • Flushes waste: Contrast and compression work together to speed up the removal of lactic acid and other byproducts.
  • Aids warm-up and recovery: Increases tissue readiness before activity and helps muscles reset and recover after.

The Hyperice X 2 Knee and Hyperice X 2 Shoulder are available now in the U.S. at hyperice.com, Best Buy, Dick’s Sporting Goods, and REI for $449. In Europe and the UK, the same cutting-edge technology will be available at hyperice.com as Hyperice Contrast 2 on September 15, retailing for £399 or €449.

Assets can be found HERE.

About Hyperice

Hyperice is a technology-driven company with a giant mission, to help everyone on Earth move and live better. For more than a decade, Hyperice has led a global movement at the confluence of recovery and wellness, specializing in percussion (Hypervolt line), dynamic air compression (Normatec line), vibration (Vyper and Hypersphere lines), thermal technology (Venom line), contrast therapy (Hyperice X), and Hyperboot collaboration with Nike. Now, as a holistic high-performance wellness brand, Hyperice is designed for all - from the most elite athletes, leagues, and teams to consumers everywhere looking to unlock the best version of themselves to help them do what they love, more. Recognized as one of Fast Company’s Most Innovative Companies and a TIME Best Inventions winner, Hyperice has applied its technology and know-how to industries including fitness, hospitality, healthcare, massage, physical therapy, sports performance, and workplace wellness on a global scale. For more information, visit hyperice.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250819036830/en/

Contacts

MEDIA CONTACT:
Will McClaran
Jack Taylor PR
hyperice@jacktaylorpr.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

www.businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

The Rock-It Company Expands Dynamic Dox to Provide ATA Carnet Services Across the US and Canada9.9.2026 18:00:00 EEST | Press release

The Rock-It Company announced today the expansion of Dynamic Dox, the industry-leading provider of ATA Carnets, to now service partners and projects based in the United States, Canada and beyond. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260909137375/en/ Following over a decade of expertise and leading service across the United Kingdom since 2014, Dynamic Dox will now provide new regions with dedicated document preparation for time-sensitive logistics projects, and urgent ATA Carnets for international shipments and critical business travel needs. The news of the expansion follows Dynamic Dox’s recent brand refresh, introducing an updated identity and connection to The Rock-It Company as Dynamic Dox By Rock-It. The expansion is led by Amanda Barlow, VP of Global ATA Carnets at The Rock-It Company, who has helped to drive the platform’s growth in ATA Carnets, customs services and beyond. The Rock-It Company recently enabl

Ennov Appoints Oxana Pickeral as Chief Executive Officer9.9.2026 17:00:00 EEST | Press release

Ennov (the “Company”), a global provider of a unified compliance platform that streamlines regulatory, clinical, quality, and pharmacovigilance operations for life sciences and healthcare companies, today announced the appointment of Dr. Oxana Pickeral as Chief Executive Officer. Founder and outgoing CEO, Olivier Pâris, will join Ennov’s Board of Directors and continue to support the company as a Strategic Advisor. Dr. Pickeral has spent her career at the forefront of innovation in life sciences technology, from her early work on the Human Genome Project to growing Amazon Web Services’ Healthcare & Life Sciences partner business, enabling modern cloud solutions across the industry. She joins Ennov most recently from Honeywell, where she served as Global Software and Connected Life Sciences business leader, and previously as President and CEO of Sparta Systems, a Honeywell company. Across her leadership roles, she has successfully scaled global companies at the intersection of life scie

Three Chugai Researchers Behind the Discovery of Hemlibra for Hemophilia A Receive Prestigious U.S. Lasker Award, One of the World’s Most Respected Scientific Honors9.9.2026 16:45:00 EEST | Press release

Chugai Pharmaceutical Co., Ltd. (TOKYO: 4519) today announced that Dr. Kunihiro Hattori (former Senior Fellow of Chugai), Dr. Takehisa Kitazawa (Deputy Head of Research Division, Chugai), and Dr. Tomoyuki Igawa (Head of Research Division, Chugai), who led the creation of Hemlibra (emicizumab), a treatment for hemophilia A, have been awarded the Lasker-DeBakey Clinical Medical Research Award, one of the world's most prestigious scientific honors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260909923883/en/ From left: Dr. Kitazawa, Dr. Hattori, and Dr. Igawa Hemophilia A is caused by a deficiency of coagulation Factor VIII, one of the proteins required for normal blood clotting. When activated, Factor VIII serves as a bridge that facilitates the activation of Factor X by activated Factor IX on the surface of activated platelets. The award recognizes the unconventional concept of replacing this function of Factor VIII with a

AMCS Appoints Richard Humphrey as Chief Product and Technology Officer9.9.2026 16:00:00 EEST | Press release

AMCS, a leading technology provider for the waste and recycling industry, today announced the appointment of Richard Humphrey as Chief Product and Technology Officer. Based in Boston, Humphrey will lead the company’s global product organisation. Humphrey brings more than 25 years of experience developing software for construction and other complex industrial environments. He joins AMCS as the company deepens its focus on waste and recycling and expands the role of AI across its platform. Most recently, Humphrey served as Chief Product and Technology Officer at Contruent, where he led product strategy for a construction cost-management platform used on major capital programmes. He previously held vice president roles at Bentley Systems and B2W Software. Earlier in his career, he spent more than a decade at Autodesk, where he led its Civil Design and Construction software business as Senior Director. “Richard understands what it takes to build software for industries where the work is ex

BBH Launches a New Technology Business, Braid, Solving for Intelligent Data Transformation9.9.2026 15:45:00 EEST | Press release

Brown Brothers Harriman (BBH) today announced the launch of a new technology affiliate, Braid LLC, focused on solving enterprise data transformation for financial services. Braid offers an AI-native data transformation platform that gives firms a scale solution to transform, connect, and manage their data with confidence. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260909294398/en/ Braid empowers teams to build, automate, and oversee reliable production-grade data transformations in a fraction of the time typically required today. Instead of requiring engineers to build data automations, Braid allows business users to describe their needs in natural language that AI agents use to build intelligent data transformations that are transparent and fully auditable. Braid’s enterprise-grade engine then processes and delivers those data transformations in a controlled and deterministic environment. Built by financial services exp

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye